Understanding the biological effects of SARS-CoV-2 persistence in children

FHS
June 29, 2023
7:33 am

Researchers analyzed the most recent knowledge about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Bulevirtide/Pegylated Interferon Combo Beats Monotherapy for Chronic Hepatitis D

Treatment with the investigational drug bulevirtide plus pegylated interferon alfa-2a (PegIFNα) resulted in more patients achieving undetectable levels of hepatitis D virus (HDV) RNA compared

June 7, 2024

Biocytogen, Radiance partner for bispecific antibody-drug conjugate

Share this article The partnership aims to advance the development of a first-in-class fully human anti-HER2/TROP2 BsADC for cancer treatments. Credit: Spectral-Design/shutterstock.com. Biocytogen Pharmaceuticals and

January 9, 2024

Stroke Survivors Still Prescribed a ‘Concerning’ Amount of Benzos

More vigilance may be needed regarding the amount of benzodiazepines being dispensed to older stroke survivors, though prescription patterns at the national level have improved

October 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.